PRIX GALIEN

After the 1st Galien Forum, participate in the industry's most coveted awards ceremony at the American Museum of Natural History

1st Galien Forum Program

Registration

Galien Awards Ceremony Program

Registration

Recognizing and rewarding bio-scientific efforts in

health care therapies that improve the global human condition

Prix Galien is more than an award – it is a movement with a mandate to foster, recognize and reward excellence in scientific innovation to improve the state of human health. Building on an unrivaled network of Nobel laureates in medicine and with the ethical leadership of Peace Prize winner Pr. Elie Wiesel, The Galien Foundation manages an independent, cross-functional and geographically diverse program of events and sponsorships to brand the “the best of the best” in new medicines and diagnostics.

Our scope is global and our commitment to progress in medicine is both measurable and concrete. Our members and sponsors express it through the establishment of productive relationships to build lasting bridges between the commercial research enterprise and local communities engaged in public policy, science, finance, academic research and the media. In addition to recognizing advances in promising therapies, Prix Galien brings a unique focus to the intersection between science and politics with its annual pro bono award on humanitarian achievements at the broader institutional level.

In each case, the outcome we seek is guided by the synthesis principle that underpins the conduct of science itself: successful innovation, where physical assets, knowledge and skills are combined from many sources to move new ideas quickly “from the bench to the bedside,” on behalf of patients everywhere.

In furtherance of its mission, The Galien Foundation conducts, on a yearly basis, the Prix Galien USA awards competition held at the American Museum of Natural History in New York City. Prix Galien USA is awarded in four categories that offer broad implications for future biomedical research: (i) Best pharmaceutical agent, (ii) Best biotechnology product, (iii) Special therapeutic development, and (iv) Best medical device. Candidates are vetted, and winners are chosen by an eminent jury of clinicians, scientists and academicians with expertise across all therapeutic categories. Seven of the jurors are Nobel Prize laureates.

On September 28, 2010, Prix Galien will convene in New York for its first truly global program, tallying the latest, most promising product innovations across its existing network of 12 countries in Europe and North America, but also including a review of contributions from a new generation of innovators representing diverse sectors in health as well as from the emerging markets of the developing world. Our theme is that better cross cultural contacts, harmonized regulation, internal business process improvements, new information technologies, and effective public-private partnerships can not only remove barriers to the commercialization of good medicines but expand access to these benefits, to all who need them.

It will represent a new and exciting stage in the evolution of Prix Galien as the pre-eminent force populaire behind the global scientific enterprise. With the support of our sponsoring organizations, our efforts will extend to all who see medicines innovation as not only an industrial policy asset but a source of social progress – where private enterprise and public engagement combine to deliver a greater public good.

We invite all communities with a commitment to the conduct and promotion of life sciences innovation to contribute to this important work.

Le contenu de cette page nécessite une version plus récente d’Adobe Flash Player.